PJP News and Press, Invesco Dynamic Pharmaceuticals From 11/13/25

2025-11-13 05:41:00 ET By Tony DeSpirito Are U.S. stocks approaching bubble territory or is the bull run able to press on? Active investor Tony DeSpirito is optimistic but says pockets of bubble-like exuberance could create mispricings ― making it “an exciting ti...

2025-11-11 10:13:00 ET Healthcare stocks – oversold opportunity or a value trap? The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. This disconnect from fundamentals has cr...

2025-11-04 10:01:00 ET Transcript Jim Cramer: If you just do stocks like I see too many people, there's a good chance that you might lose it all.... Read the full article on Seeking Alpha For further details see: Jim Cramer On Investing - How To Make Money In Any...

2025-11-01 03:00:00 ET Innovation remains one of the most persistent drivers of long-term growth – reshaping industries, creating new markets, and sustaining momentum through economic cycles. Yet, identifying trends alone is no longer sufficient. Investors must recognize how them...

2025-10-22 05:26:48 ET More on Pfizer, Johnson & Johnson, etc. AstraZeneca PLC (AZN) Presents at ESMO Congress 2025 - Slideshow Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript Roche Holding AG (RHHBY) Shareholder/Analyst Call - Slideshow Clea...

2025-10-21 08:52:00 ET With the Fed walking a policy tightrope, investors should resist being complacent about risks and kicking the can down the road. There are opportunities across asset classes for those willing to be selective and carry a dose of caution as they assemble investmen...

2025-10-20 12:15:00 ET Trade tensions between the world’s two largest economies have flared up again. This time, so-called choke points are the focus, involving rare earth minerals and semiconductor technology. Kevin Hebner, Managing Director and Global Investment Strategist for ...

2025-10-18 02:30:00 ET By Zain Vawda Week in review Another week has passed by, and the US government shutdown continues. Despite this, the week was still full of volatility as markets grappled with the ongoing US-China stalemate as well as concerns around the US banking sec...

2025-10-10 06:30:00 ET While the threat of tariffs and drug pricing pressures have weighed on the outlook for healthcare stocks recently, some parts of the sector are beginning to stage a recovery. Ram Sampath, VP, Portfolio Research with TD Asset Management, joins MoneyTalk to discuss why ...

2025-10-09 04:22:22 ET More on pharma sector Why The Pfizer-Trump Deal Is A Win For Branded Pharma, But Not For Consumers President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio HHS ramps up drug pricing efforts with another proposed rule sent f...